Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A Latin American experience with levonorgestrel IUD

A Faúndes1, F Alvarez, J Díaz

  • 1State University of Campinas, Brazil.

Annals of Medicine
|April 1, 1993
PubMed
Summary

The levonorgestrel-releasing IUD (LNg IUD) offers highly effective, long-lasting contraception while reducing menstrual blood loss. This method significantly improved iron levels in users, with zero pregnancies over seven years.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The opinion of Brazilian women regarding vaginal labor and cesarean section.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
Same author

Conference agreement on the definition of humanization and humanized care.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
Same author

Factors and outcomes associated with the induction of labour in Latin America.

BJOG : an international journal of obstetrics and gynaecology·2009
Same author

The medical profession and the defense and promotion of sexual and reproductive rights.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2007
Same author

Misoprostol for induction of labor with a live fetus.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2007
Same author

Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2007

Area of Science:

  • Reproductive Health
  • Contraception
  • Endocrinology

Background:

  • Intrauterine devices (IUDs) are effective contraceptives but can increase menstrual blood loss, posing challenges in populations with high anemia prevalence.
  • The levonorgestrel-releasing IUD (LNg IUD) is a novel contraceptive designed to overcome this limitation.

Purpose of the Study:

  • To evaluate the efficacy, safety, and impact on menstrual blood loss of the LNg IUD.
  • To assess user acceptance and discontinuation reasons for the LNg IUD in diverse populations.

Main Methods:

  • A clinical trial involving 200 volunteers in the Dominican Republic and 381 in Brazil.
  • Monitoring of pregnancy rates, menstrual blood loss, ferritin levels, levonorgestrel plasma levels, and endometrial histology.
  • Tracking of reasons for discontinuation over up to seven years of use.

Main Results:

  • Achieved a cumulative pregnancy rate of 0% over seven years.
  • Demonstrated significant reduction in menstrual bleeding and increased ferritin levels compared to copper IUD and non-contraceptive users.
  • Amenorrhea was the primary reason for discontinuation (10-15% cumulative rates).

Conclusions:

  • The LNg IUD is a highly effective and well-tolerated reversible contraceptive method.
  • It offers a significant advantage by reducing menstrual blood loss and improving iron status.
  • The LNg IUD is expected to be well-accepted and fill an important niche in contraceptive options.

Related Experiment Videos